Royal Bank of Canada’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $40.2M | Buy |
199,981
+45,112
| +29% | +$9.33M | 0.01% | 1033 |
|
|
2025
Q4 | $32M | Buy |
154,869
+2,167
| +1% | +$433K | 0.01% | 1170 |
|
|
2025
Q3 | $27.4M | Sell |
152,702
-971
| -0.6% | -$165K | ﹤0.01% | 1408 |
|
|
2025
Q2 | $24.8M | Sell |
153,673
-5,116
| -3% | -$815K | ﹤0.01% | 1381 |
|
|
2025
Q1 | $27M | Buy |
158,789
+4,652
| +3% | +$808K | 0.01% | 1119 |
|
|
2024
Q4 | $25.6M | Sell |
154,137
-4,265
| -3% | -$729K | 0.01% | 1200 |
|
|
2024
Q3 | $27.2M | Sell |
158,402
-22,774
| -13% | -$3.77M | 0.01% | 1157 |
|
|
2024
Q2 | $27.9M | Buy |
181,176
+8,272
| +5% | +$1.24M | 0.01% | 1067 |
|
|
2024
Q1 | $26.6M | Sell |
172,904
-49,560
| -22% | -$7.56M | 0.01% | 1098 |
|
|
2023
Q4 | $35.2M | Buy |
222,464
+583
| +0.3% | +$83.8K | 0.01% | 938 |
|
|
2023
Q3 | $32.5M | Sell |
221,881
-5,560
| -2% | -$847K | 0.01% | 898 |
|
|
2023
Q2 | $34.8M | Sell |
227,441
-3,898
| -2% | -$608K | 0.01% | 859 |
|
|
2023
Q1 | $35.9M | Buy |
231,339
+21,505
| +10% | +$3.38M | 0.01% | 818 |
|
|
2022
Q4 | $32.3M | Buy |
209,834
+8,927
| +4% | +$1.32M | 0.01% | 877 |
|
|
2022
Q3 | $26.5M | Buy |
200,907
+18,485
| +10% | +$2.59M | 0.01% | 914 |
|
|
2022
Q2 | $24.7M | Sell |
182,422
-22,603
| -11% | -$3.12M | 0.01% | 987 |
|
|
2022
Q1 | $30.6M | Sell |
205,025
-710
| -0.3% | -$105K | 0.01% | 988 |
|
|
2021
Q4 | $33.3M | Buy |
205,735
+14,443
| +8% | +$2.34M | 0.01% | 1073 |
|
|
2021
Q3 | $31.8M | Sell |
191,292
-11,611
| -6% | -$1.98M | 0.01% | 1014 |
|
|
2021
Q2 | $35M | Sell |
202,903
-39,501
| -16% | -$6.52M | 0.01% | 957 |
|
|
2021
Q1 | $38.9M | Sell |
242,404
-1,043
| -0.4% | -$179K | 0.01% | 828 |
|
|
2020
Q4 | $40.9M | Sell |
243,447
-16,732
| -6% | -$2.71M | 0.01% | 795 |
|
|
2020
Q3 | $40.9M | Buy |
260,179
+9,735
| +4% | +$1.59M | 0.01% | 704 |
|
|
2020
Q2 | $42M | Buy |
250,444
+15,731
| +7% | +$2.47M | 0.02% | 643 |
|
|
2020
Q1 | $30.8M | Sell |
234,713
-19,040
| -8% | -$2.71M | 0.01% | 684 |
|
|
2019
Q4 | $37.7M | Buy |
253,753
+17,418
| +7% | +$2.39M | 0.01% | 757 |
|
|
2019
Q3 | $29.3M | Sell |
236,335
-52,426
| -18% | -$6.98M | 0.01% | 837 |
|
|
2019
Q2 | $40.7M | Buy |
288,761
+29,518
| +11% | +$4.07M | 0.02% | 674 |
|
|
2019
Q1 | $39.1M | Buy |
259,243
+14,324
| +6% | +$2.06M | 0.02% | 676 |
|
|
2018
Q4 | $30.4M | Buy |
244,919
+31,023
| +15% | +$4.24M | 0.01% | 751 |
|
|
2018
Q3 | $33.9M | Buy |
213,896
+55,386
| +35% | +$8.38M | 0.01% | 803 |
|
|
2018
Q2 | $22.2M | Buy |
158,510
+23,687
| +18% | +$3.25M | 0.01% | 1012 |
|
|
2018
Q1 | $17.9M | Buy |
134,823
+6,679
| +5% | +$912K | 0.01% | 1166 |
|
|
2017
Q4 | $16M | Buy |
128,144
+16,722
| +15% | +$2.07M | 0.01% | 1284 |
|
|
2017
Q3 | $13.8M | Buy |
111,422
+12,333
| +12% | +$1.46M | 0.01% | 1329 |
|
|
2017
Q2 | $11.3M | Sell |
99,089
-1,376
| -1% | -$148K | 0.01% | 1432 |
|
|
2017
Q1 | $10.6M | Buy |
100,465
+15,875
| +19% | +$1.59M | 0.01% | 1456 |
|
|
2016
Q4 | $7.69M | Buy |
84,590
+2,420
| +3% | +$227K | ﹤0.01% | 1670 |
|
|
2016
Q3 | $8.19M | Buy |
82,170
+12,221
| +17% | +$1.2M | ﹤0.01% | 1615 |
|
|
2016
Q2 | $6.26M | Sell |
69,949
-25,914
| -27% | -$2.38M | ﹤0.01% | 1763 |
|
|
2016
Q1 | $8.39M | Sell |
95,863
-76,175
| -44% | -$6.71M | 0.01% | 1498 |
|
|
2015
Q4 | $19.4M | Sell |
172,038
-20,317
| -11% | -$2.19M | 0.01% | 995 |
|
|
2015
Q3 | $19.5M | Sell |
192,355
-34,718
| -15% | -$4.13M | 0.01% | 778 |
|
|
2015
Q2 | $28.2M | Buy |
227,073
+9,402
| +4% | +$1.13M | 0.02% | 633 |
|
|
2015
Q1 | $25.7M | Buy |
217,671
+6,113
| +3% | +$691K | 0.02% | 691 |
|
|
2014
Q4 | $21.6M | Sell |
211,558
-20,215
| -9% | -$1.97M | 0.01% | 814 |
|
|
2014
Q3 | $21.3M | Buy |
231,773
+74,534
| +47% | +$6.47M | 0.01% | 766 |
|
|
2014
Q2 | $12.9M | Buy |
157,239
+10,856
| +7% | +$830K | 0.01% | 1056 |
|
|
2014
Q1 | $11.2M | Sell |
146,383
-40,669
| -22% | -$3.17M | 0.01% | 1090 |
|
|
2013
Q4 | $12.9M | Buy |
187,052
+76,485
| +69% | +$5.02M | 0.01% | 1045 |
|
|
2013
Q3 | $7.17M | Buy |
110,567
+17,675
| +19% | +$1.12M | 0.01% | 1333 |
|
|
2013
Q2 | $5.41M | Buy |
+92,892
| New | +$5.31M | ﹤0.01% | 1403 |
|
Other funds holding FBT
BFG
NP
Royal Bank of Canada's FBT Position: Q1 2026 in Review
Royal Bank of Canada increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 29% in Q1 2026, buying an estimated $9.33M and bringing the position to 199,981 shares worth $40.2M. The position accounts for 0.01% of the portfolio, ranked #1033.
Royal Bank of Canada first reported a position in FBT in Q2 2013 and has held it in 52 quarters since. The position peaked at $42M in Q2 2020. 308 funds tracked by Wall St. Rank hold FBT as of Q1 2026.
- Royal Bank of Canada held 199,981 shares of First Trust NYSE Arca Biotechnology Index Fund worth $40.2M as of Q1 2026.
- Royal Bank of Canada bought 45,112 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $9.33M.
- First Trust NYSE Arca Biotechnology Index Fund made up 0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #1033 holding.
- Royal Bank of Canada first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q2 2013 and has held it in 52 quarters since.
- Royal Bank of Canada's First Trust NYSE Arca Biotechnology Index Fund position peaked at $42M in Q2 2020.
- 308 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.